Emeritus’ leading Rheumatologists have been working with global pharmaceutical companies for over 20 years, and have been part of research that developed many of today’s leading medicines.
Osteoarthritis is the most common disease affecting the joints, with more than 250 million people worldwide impacted. Osteoarthritis is characterised by the progressive breakdown of cartilage, which can lead to chronic pain, stiffness and disability. Treatments including non steroidal anti-inflammatories, analgesics, physical therapy and joint injections only focus on reducing pain and improving knee function. The effectiveness of these therapies vary widely from person to person.
Emeritus Research has conducted over 10 trials in the field of osteoarthritis, more typically for knee osteoarthritis. The investigational products have ranged from potentially new pain relief medications to treatments that could regenerate cartilage in the joint and can be in the form of intra-articular or subcutaneous injections.
If you’re interested in learning more about our osteoarthritis trials please express your interest by filling out the below google form